MGMT and glioblastoma: Standard treatments, including surgery, radiotherapy, and temozolomide, provide limited survival benefits, largely due to therapy evasion mechanisms such as GBM stem cell survival, P-glycoprotein activity, and MGMT overexpression, leading to recurrence and resistance.